Manufacturing and Production

Showing 15 posts of 5872 posts found.

facilities_lg06

13 FDA observations on Dr Reddy’s plant send shares to 3 year low

March 9, 2017 Manufacturing and Production Dr Reddy's, FDA

Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017 Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017 Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …
shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017 Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …

Merck’s Allergopharma opens €42m biopharmaceutical plant

March 7, 2017 Manufacturing and Production Allergopharma, Merck

Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017 Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …
sink

FDA approves first treatment for excessive night-time urination

March 6, 2017 Manufacturing and Production FDA, Noctiva, Serenity

The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …

Bioverativ adds new member to board of directors

March 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …

Ipsen appoints new Executive Vice President

March 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …
shutterstock_128521253

Are we prepared for the ‘real world’?

March 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment

Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …
scott_smith_252

New COO for Celgene

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

Pfizer plant receives FDA warning letter for contamination of medicine

March 1, 2017 Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …
The Gateway to Local Adoption Series

Latest content